David G. Bostwick MD, MBA

Dr. David G. Bostwick, MD, MBA is the founder and Chief Executive Officer of Bostwick Laboratories (a division of Poplar Healthcare), Chief Medical Officer of Granger Genetics, and Chief Medical Officer of Rampart Health. He trained at the University of Maryland and Stanford University and was formerly a Professor of Urology and Pathology at the Mayo Clinic from 1991 to 1999. Dr. Bostwick is internationally renowned, with 40 years of experience and interest in prostate cancer, bladder cancer, and urologic diseases. He has previously held appointments at the National Cancer Institute, Stanford University, University of Chicago, University of Maryland, and Mayo Clinic. He has authored 17 books, more than 25 book chapters, and more than 450 professional papers. His textbook, Urologic Surgical Pathology, (WB Saunders, 3rd Edition, 2014) is the best-selling book in Uropathology.

Dr. Bostwick published more papers with the keywords “prostate cancer” in the decade from 1990 to 2000 than any other investigator (independent MedLine review, 2001). He is also the most sought-after pathologist for second opinions in prostate pathology. Dr. Bostwick founded and served as the President of the International Society of Urological Pathology. He has presented more than 2000 lectures around the world, and served as Principal Investigator or Co-Investigator for more than 10 clinical trials Other former best-sellers are his books American Cancer Society’s Complete Guide to Prostate Cancer (American Cancer Society, 2005) and Essentials of Pathology, 4th Edition (Springer 2017). His most quoted works include the first descriptions of the origin of prostate cancer (prostatic intraepithelial neoplasia) and the most important mimic of prostate cancer (atypical small acinar proliferation). He is currently pursuing novel approaches to immunotherapy for metastatic cancer.